PNC-27 offers attractive prices, high purity and safe transportation.
3 Inquiries
1159861-00-3
Pharmaceutical Grade
99%
SHENZHEN
SH
10mg/vial
2026-07-05
Peptides
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferencePNC-27 is an anti-cancer peptide that, in small in-vitro studies, has been shown to induce tumour cell necrosis. It is not currently approved for use in the United States (U.S.) and is currently being marketed online as a non-toxic potential cure for various cancers. Recently, the FDA issued warnings to the public regarding PNC-27 use, suggesting possible contamination and unknown side effects of the treatment. PNC-27 may be available in various dosage forms, such as a nebulized solution, intravenous solution, vaginal suppository, or rectal suppository. FDA has not evaluated or approved PNC-27 as safe and effective in treating any disease, including cancer[1].
PNC-27 is an anticancer peptide, containing an HDM-2-binding domain. PNC-27 shows anti-tumor activity and can be used in acute myeloid leukemia research.Basic Info-
Product Name:
PNC-27
Other Name:PNC27
CAS No.:1159861-00-3
Molecular Weight:0
Categories:
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptides
-
Location:
Shanxi An Da Si Hai Technology Co., Ltd.
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2025
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted
United States
PNC27
10 PCS Apr 11, 2026
United States
PNC-27
1 PCS Sep 4, 2026
United States
PNC-27
5 MG Sep 4, 2026 Post an enquiry for this product